A Step Ahead of Resistance; Virco introduces an Improved Rapid Methodology to Establish New HIV-1 Resistance Profiles

MECHELEN, Belgium – Oct. 16 (SEND2PRESS NEWSWIRE) — Responding to the need to make timely evaluations and decisions when treating treatment experienced HIV patients, Virco, a leader in drug resistance testing recently introduced an improved virco(R)TYPE HIV-1 test that rapidly determines the complex phenotypic resistance profiles for darunavir, tipranavir and other antiretroviral (ARV) drugs.